{"url_path":"/sec/sonm/8-k/2026-05-20/item-2-02","section_key":"item-2-02","section_title":"Item 2.02 Results of Operations and Financial Condition.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-20","source_url":"https://www.sec.gov/Archives/edgar/data/1178697/0001493152-26-024639-index.html","accession_number":"0001493152-26-024639","cik":"0001178697","ticker":"SONM","issuer_name":"DNA X, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1178697/0001493152-26-024639-index.html","primary_entity_key":"0001178697","primary_entity_name":"DNA X, Inc."},"word_count":54,"has_tables":true,"body_markdown":"**Item\n2.02. Results of Operations and Financial Condition.**\n\n \n\nOn\nMay 20, 2026, DNA X, Inc. (the “Company”) issued a press release announcing its financial results for the fiscal quarter\nended March 31, 2026 (the “Press Release”). A copy of the Press Release is furnished as Exhibit 99.1 to this Current Report\non Form 8-K."}